{"id":1076,"date":"2009-09-01T12:02:00","date_gmt":"2009-09-01T10:02:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/2009\/opioid-antagonisten-zur-therapie-der-opioid-induzierten-obstipation"},"modified":"2009-09-01T12:02:00","modified_gmt":"2009-09-01T10:02:00","slug":"opioid-antagonisten-zur-therapie-der-opioid-induzierten-obstipation","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/2009\/opioid-antagonisten-zur-therapie-der-opioid-induzierten-obstipation","title":{"rendered":"Opioid-Antagonisten zur Therapie der Opioid-induzierten Obstipation?"},"content":{"rendered":"<p>Zusammenfassung: Eine sehr h\u00e4ufige und bel\u00e4stigende UAW der Opioid-Therapie ist Obstipation. Sie kann dazu f\u00fchren, dass das Opioid niedriger dosiert oder sogar abgesetzt werden muss. Helfen die \u00fcblichen laxierenden Ma\u00dfnahmen nicht, k\u00f6nnen durch die peripher angreifenden Opioid-Antagonisten Naloxon (in fixer Kombination mit Oxycodon in Targin\u00ae enthalten) bzw. Methylnaltrexon (Relistor\u00ae) und Alvimopan (Entereg\u00ae) die unerw\u00fcnschten gastrointestinalen [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Zusammenfassung: Eine sehr h\u00e4ufige und bel\u00e4stigende UAW der Opioid-Therapie ist Obstipation. Sie kann dazu f\u00fchren, dass das Opioid niedriger dosiert oder sogar abgesetzt werden muss. Helfen die \u00fcblichen laxierenden Ma\u00dfnahmen nicht, k\u00f6nnen durch die peripher angreifenden Opioid-Antagonisten Naloxon (in fixer Kombination mit Oxycodon in Targin\u00ae enthalten) bzw. Methylnaltrexon (Relistor\u00ae) und Alvimopan (Entereg\u00ae) die unerw\u00fcnschten gastrointestinalen [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[2687,2152,2690,2149,2145,2691,13,2688,16,2147,2689,2136],"class_list":["post-1076","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-alvimopan","tag-laxanzien","tag-methylnaltrexon","tag-naloxon","tag-obstipation","tag-opiat-antagonisten","tag-opiate","tag-opioid-antagonisten","tag-opioide","tag-oxycodon","tag-oxycodon-naloxon","tag-verstopfung"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/1076","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=1076"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/1076\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=1076"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=1076"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=1076"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}